CG Oncology (CGON) Gross Profit (2024 - 2026)
CG Oncology posted quarterly Gross Profit of -$1.9 million for Q1 2026, down 3713.46% year-on-year from $52000.0 in Q1 2025, and down 151.2% on a QoQ basis from -$748000.0 in Q4 2025.
CG Oncology (CGON) has 3 years of Gross Profit data on file, last reported at -$1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit fell 3713.46% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (changed N/A YoY), and the FY2025 full-year result was -$607000.0, down 153.29% from the prior year.
- Gross Profit for Q1 2026 stood at -$1.9 million, down from -$748000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $456000.0 in Q4 2024 and bottomed at -$1.9 million in Q1 2026.
- The 3-year median for Gross Profit is $47500.0 (2024), against an average of -$331166.7.
- The widest annual swing landed in 2025, when Gross Profit jumped 106.98%; it then tumbled 3713.46% in 2026.
- A 3-year view of Gross Profit shows it stood at $456000.0 in 2024, then sank by 264.04% to -$748000.0 in 2025, then plunged by 151.2% to -$1.9 million in 2026.
- The last three Gross Profit figures came in at -$1.9 million (Q1 2026), -$748000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.88 Mn |
| Mar 31, 2026 | -1.88 Mn |
| Dec 31, 2025 | -748,000.00 |
| Dec 31, 2025 | -748,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |